Improved Immunogenicity of Recombinant Mycobacterium bovis Bacillus Calmette‐Guérin Strains Expressing Fusion Protein Ag85A‐ESAT‐6 of Mycobacterium tuberculosis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Scandinavian Journal of Immunology

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-3083.2010.02444.xPMID 20883318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives

  2010cited by this paper
• Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers.

  2010cited by this paper
• Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis.

  2009cited by this paper
• Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.

  2009cited by this paper
• Tuberculosis–HIV co‐infection: policy and epidemiology in 25 countries in the WHO European region

  2008cited by this paper
• Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis1

  2008cited by this paper
• Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model.

  2008cited by this paper
• Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.

  2007cited by this paper
• Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine.

  2006cited by this paper
• Phenotypical and Functional Analysis of Memory and Effector Human CD8 T Cells Specific for Mycobacterial Antigens1

  2006cited by this paper
• Contribution of CD8+ T Cells to Control of Mycobacterium tuberculosis Infection1

  2006cited by this paper
• Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection.

  2006cited by this paper
• Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting.

  2004cited by this paper
• The TB epidemic from 1992 to 2002.

  2003cited by this paper
• Mapping of Murine Th1 Helper T-Cell Epitopes of Mycolyl Transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

  2003cited by this paper
• Virulence, Immunogenicity, and Protective Efficacy of Two Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Strains Expressing the Antigen ESAT-6 from Mycobacterium tuberculosis

  2003cited by this paper
• Disruption of the Genes Encoding Antigen 85A and Antigen 85B ofMycobacterium tuberculosis H37Rv: Effect on Growth in Culture and in Macrophages

  2000cited by this paper
• Comparative genomics of BCG vaccines by whole-genome DNA microarray.

  1999cited by this paper
• Mapping of V beta 11+ helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis.

  1997cited by this paper
• Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG

  1996cited by this paper
• Functions of T-cell subsets and cytokines in mycobacterial infections.

  1995cited by this paper
• New use of BCG for recombinant vaccines

  1991cited by this paper

• A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19

  2022cites this paper
• Bacillus Calmette-Guerin (BCG) in immunotherapy of ovarian tumors: from the beginning to recent findings. May it still be relevant?

  2021cites this paper
• Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70

  2017cites this paper
• Commonly administered bacille Calmette-Guerin strains induce comparable immune response.

  2015cites this paper
• Mycobacteriumtuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses

  2015cites this paper
• Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer

  2015cites this paper
• Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory

  2014influential citation
• A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens

  2014cites this paper
• Immunogenicity of a Synthetic Vaccine Based on Plasmodium vivax Duffy Binding Protein Region II

  2014cites this paper
• Immunogenicity of a synthetic vaccine based on the Plasmodium vivax Duffy Binding 1

  2014cites this paper
• Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.

  2014influential citation
• Immunogenicity and Protective Efficacy Conferred by a Novel Recombinant Mycobacterium bovis Bacillus Calmette‐Guérin Strain Expressing Interleukin‐12p70 of Human Cytokine and Ag85A of Mycobacterium tuberculosis Fusion Protein

  2013cites this paper
• Construction of Eukaryotic Expression Vector and Expression on Mycobacterium bovis ag85a and mpb70 Genes

  2013cites this paper
• Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection

  2013cites this paper
• Tuberculosisand Induce Protection against on Biopolyester Beads Stimulate Cellular Vaccines Displaying Mycobacterial Proteins

  2013cites this paper
• Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection.

  2012cites this paper
• Survival strategies of Mycobacterium tuberculosis inside the human macrophage

  2011cites this paper
• Vaccines Displaying Mycobacterial Proteins on Biopolyester Beads Stimulate Cellular Immunity and Induce Protection against Tuberculosis

  2011cites this paper
• A novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity.

  2011cites this paper